ORBIMED ADVISORS LLC - 07 Jul 2025 SCHEDULE 13D/A Report for Passage BIO, Inc. Common Stock (PASG)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: ORBIMED ADVISORS LLC
Security: Passage BIO, Inc. Common Stock
Symbol: PASG
Shares outstanding: 62.4M shares
Disclosed Ownership: 5.92M shares
Ownership: 9.5%
Form type: SCHEDULE 13D/A
Filing time: 09 Jul 2025, 20:06:12 UTC
Date of event: 07 Jul 2025
Previous filing: 25 Apr 2025
Next filing: 21 Jul 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIMED ADVISORS LLC	9.5%	5.92M	0	5.92M	/s/ Carl L. Gordon	Carl L. Gordon/Member	0001055951
ORBIMED CAPITAL GP VII LLC	9.5%	5.92M	0	5.92M	/s/ Carl L. Gordon	Carl L. Gordon/Member of OrbiMed Advisors LLC	0001760648